Foghorn TherapeuticsInc Valuation
| FHTX Stock | USD 5.64 0.37 6.16% |
At this time, the firm appears to be undervalued. Foghorn TherapeuticsInc shows a prevailing Real Value of $7.91 per share. The current price of the firm is $5.64. Our model computes the value of Foghorn TherapeuticsInc from reviewing the firm fundamentals such as Current Valuation of 76.5 M, profit margin of (2.74) %, and Shares Outstanding of 55.33 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Foghorn TherapeuticsInc's valuation include:
Price Book 10.707 | Enterprise Value 76.5 M | Enterprise Value Ebitda (1.21) | Price Sales 9.2472 | Enterprise Value Revenue 3.7141 |
Undervalued
Today
Please note that Foghorn TherapeuticsInc's price fluctuation is moderately volatile at this time. Calculation of the real value of Foghorn TherapeuticsInc is based on 3 months time horizon. Increasing Foghorn TherapeuticsInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Foghorn TherapeuticsInc is useful when determining the fair value of the Foghorn stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Foghorn TherapeuticsInc. Since Foghorn TherapeuticsInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Foghorn Stock. However, Foghorn TherapeuticsInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.64 | Real 7.91 | Target 15.25 | Hype 5.63 | Naive 5.37 |
The real value of Foghorn Stock, also known as its intrinsic value, is the underlying worth of Foghorn TherapeuticsInc Company, which is reflected in its stock price. It is based on Foghorn TherapeuticsInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Foghorn TherapeuticsInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Foghorn TherapeuticsInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Foghorn TherapeuticsInc helps investors to forecast how Foghorn stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Foghorn TherapeuticsInc more accurately as focusing exclusively on Foghorn TherapeuticsInc's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Foghorn TherapeuticsInc's intrinsic value based on its ongoing forecasts of Foghorn TherapeuticsInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Foghorn TherapeuticsInc's closest peers. When choosing an evaluation method for Foghorn TherapeuticsInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Foghorn TherapeuticsInc Investments |
|
Foghorn Valuation Trend
Knowing Foghorn TherapeuticsInc's actual value is paramount for traders to make sound investment determinations. Foghorn TherapeuticsInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Foghorn TherapeuticsInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Foghorn TherapeuticsInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Foghorn Market Cap
Foghorn TherapeuticsInc is rated # 3 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 2.66 Billion. Foghorn TherapeuticsInc retains roughly 312.05 Million in market capitalization claiming about 12% of equities under Health Care industry.Foghorn TherapeuticsInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Foghorn TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Foghorn TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Foghorn TherapeuticsInc competition to find correlations between indicators driving Foghorn TherapeuticsInc's intrinsic value. More Info.Foghorn TherapeuticsInc is one of the top stocks in price to book category among related companies. It is rated # 3 in price to sales category among related companies fabricating about 0.86 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for Foghorn TherapeuticsInc is roughly 1.16 . At this time, Foghorn TherapeuticsInc's Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Foghorn TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Foghorn TherapeuticsInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Foghorn TherapeuticsInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Foghorn TherapeuticsInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Foghorn TherapeuticsInc and how it compares across the competition.
About Foghorn TherapeuticsInc Valuation
The stock valuation mechanism determines the current worth of Foghorn TherapeuticsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Foghorn TherapeuticsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Foghorn TherapeuticsInc based exclusively on its fundamental and basic technical indicators. By analyzing Foghorn TherapeuticsInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Foghorn TherapeuticsInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Foghorn TherapeuticsInc. We calculate exposure to Foghorn TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Foghorn TherapeuticsInc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 25.5 M | 26.8 M | |
| Pretax Profit Margin | (2.76) | (2.90) | |
| Operating Profit Margin | (3.16) | (3.32) | |
| Net Loss | (2.88) | (3.03) | |
| Gross Profit Margin | 0.75 | 0.78 |
8 Steps to conduct Foghorn TherapeuticsInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Foghorn TherapeuticsInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Foghorn TherapeuticsInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Foghorn TherapeuticsInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Foghorn TherapeuticsInc's revenue streams: Identify Foghorn TherapeuticsInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Foghorn TherapeuticsInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Foghorn TherapeuticsInc's growth potential: Evaluate Foghorn TherapeuticsInc's management, business model, and growth potential.
- Determine Foghorn TherapeuticsInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Foghorn TherapeuticsInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Foghorn TherapeuticsInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Foghorn TherapeuticsInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 42 M |
Foghorn TherapeuticsInc Current Valuation Indicators
Valuation refers to the process of determining the present value of Foghorn TherapeuticsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Foghorn we look at many different elements of the entity such as Foghorn's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Foghorn TherapeuticsInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Foghorn TherapeuticsInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Foghorn TherapeuticsInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Foghorn TherapeuticsInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Foghorn TherapeuticsInc's worth.When determining whether Foghorn TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Foghorn TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Foghorn Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Foghorn Therapeuticsinc Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Foghorn Stock analysis
When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Foghorn TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn TherapeuticsInc. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.20) | Revenue Per Share 0.805 | Quarterly Revenue Growth (0.05) | Return On Assets (0.20) | Return On Equity (4.70) |
The market value of Foghorn TherapeuticsInc is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Foghorn TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn TherapeuticsInc's market value can be influenced by many factors that don't directly affect Foghorn TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.